The company explains that ubiquinol may be more bioavailable because it delivers CoQ10 in its native, antioxidant-ready (reduced) form.
Jarrow Formulas is continuing to focus its attention on ubiquinol, which it says offers improved bioavailability over standard supplements featuring the ubiquinone form of CoQ10. The brand has introduced two new supplements in its QH-absorb ubiquinol line for cardiovascular health: a 100-mg 120 softgel size and a 200-mg 60 softgel size.
The company explains that ubiquinol may be more bioavailable because it delivers CoQ10 in its native, antioxidant-ready (reduced) form. It says that while standard ubiquinone CoQ10 supplements can be activated in the body, this activation may be less efficient in some individuals due to age, state of health, or genetics.
QH-absorb uses an all-natural liposome-based delivery system to improve absorption and contains no detergents or surfactants. Jarrow says that this delivery system has been validated in multiple trials to significantly improve CoQ10 absorption over powered CoQ10 dosage forms. Its ubiquinol is derived from CoQ10 that is manufactured using a yeast-fermentation process and consists only of the natural trans- configurartion, the same form that is synthesized by the human body. The ubiquinol is supplied by Kaneka Corp.